YA II PN, Ltd. 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-08 2:11 pm Purchase | 2025-06-16 | 13G | Aptevo Therapeutics Inc. APVO | YA II PN, Ltd. | 357,842 9.990% | 357,842 (New Position) | Filing |